Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Cuihua Yue"'
Autor:
Min Yang, Wenwen Du, Lixian Yi, Shaoxian Wu, Chunyan He, Wensi Zhai, Cuihua Yue, Runzi Sun, Ashley V. Menk, Greg M. Delgoffe, Jingting Jiang, Binfeng Lu
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
The immune checkpoint blockade (ICB) immunotherapy has prolonged overall survival for cancer patients but the response rates are low. The resistance to ICB is likely due to compensatory upregulation of additional immune inhibitory molecules. In this
Externí odkaz:
https://doaj.org/article/f8aee54f31f8445996117a0211295b79
Autor:
Xi Yang, Rui Xia, Cuihua Yue, Wensi Zhai, Wenwen Du, Qianting Yang, Huiling Cao, Xiaojuan Chen, Danielle Obando, Yibei Zhu, Xinchun Chen, Jane-Jane Chen, Jon Piganelli, Peter Wipf, Yu Jiang, Guozhi Xiao, Changping Wu, Jingting Jiang, Binfeng Lu
Publikováno v:
Cell Reports, Vol 23, Iss 6, Pp 1754-1766 (2018)
Summary: T cells are strongly regulated by oxidizing environments and amino acid restriction. How T cells reprogram metabolism to adapt to these extracellular stress situations is not well understood. Here, we show that oxidizing environments and ami
Externí odkaz:
https://doaj.org/article/87d9444563a9443496742d8bcc590b17
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193428 (2018)
Lung cancer is one of the deadliest malignancies. The immune checkpoint-blockade (ICB) tumor therapy has led to striking improvement of long-term survival for some lung cancer patients. However, the response rate of immunotherapy is still low for lun
Externí odkaz:
https://doaj.org/article/a92f5e34496f47b99298847b31f6329b
Autor:
Binfeng Lu, Jingting Jiang, Heth Turnquist, Song Li, Yichao Chen, Cuihua Yue, Min Yang, Dachuan Zhang, Wensi Zhai, Junchi Xu, Runzi Sun, Lujun Chen
Characteristics of TIL in ST2+/+ and ST2-/- mice after ICB therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eefa2ea3c4a41aedb2a38ab795120c6
https://doi.org/10.1158/2326-6066.22543729
https://doi.org/10.1158/2326-6066.22543729
Autor:
Binfeng Lu, Jingting Jiang, Heth Turnquist, Song Li, Yichao Chen, Cuihua Yue, Min Yang, Dachuan Zhang, Wensi Zhai, Junchi Xu, Runzi Sun, Lujun Chen
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb63a6a9d5212bb4012ee9d17eb1b39a
https://doi.org/10.1158/2326-6066.22543711
https://doi.org/10.1158/2326-6066.22543711
Autor:
Binfeng Lu, Jingting Jiang, Heth Turnquist, Song Li, Yichao Chen, Cuihua Yue, Min Yang, Dachuan Zhang, Wensi Zhai, Junchi Xu, Runzi Sun, Lujun Chen
Immune checkpoint blockade (ICB) immunotherapy has revolutionized cancer treatment by prolonging overall survival of patients with cancer. Despite advances in the clinical setting, the immune cellular network in the tumor microenvironment (TME) that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d58a21be76e4638f9337a5061ad2ca3
https://doi.org/10.1158/2326-6066.c.6550375
https://doi.org/10.1158/2326-6066.c.6550375
Autor:
Cuihua Yue, Binfeng Lu, Wensi Zhai, Min Yang, Chen Lujun, Runzi Sun, Jingting Jiang, Yichao Chen, Heth R. Turnquist, Dachuan Zhang, Song Li, Junchi Xu
Publikováno v:
Cancer Immunol Res
Immune checkpoint blockade (ICB) immunotherapy has revolutionized cancer treatment by prolonging overall survival of patients with cancer. Despite advances in the clinical setting, the immune cellular network in the tumor microenvironment (TME) that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98f00db58a8f4153a449229c6a6648a
https://europepmc.org/articles/PMC7642190/
https://europepmc.org/articles/PMC7642190/
Autor:
Binfeng Lu, Wenwen Du, Cuihua Yue, Wensi Zhai, Greg M. Delgoffe, Runzi Sun, Chunyan He, Min Yang, Shaoxian Wu, Jingting Jiang, Lixian Yi, Ashley V. Menk
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Oncoimmunology
Oncoimmunology
The immune checkpoint blockade (ICB) immunotherapy has prolonged overall survival for cancer patients but the response rates are low. The resistance to ICB is likely due to compensatory upregulation of additional immune inhibitory molecules. In this
Publikováno v:
Oncology Letters
Previous studies have demonstrated that the interleukin (IL)-6/ IL-6 receptor (IL-6R) signaling pathway contributes to the pathogenesis of lung cancer. Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the two major pathological
Autor:
Yibei Zhu, Xi Yang, Guozhi Xiao, Rui Xia, Wenwen Du, Jon D. Piganelli, Wensi Zhai, Binfeng Lu, Xiaojuan Chen, Jane-Jane Chen, Qianting Yang, Peter Wipf, Huiling Cao, Xinchun Chen, Cuihua Yue, Changping Wu, Danielle Obando, Yu Jiang, Jingting Jiang
Publikováno v:
Cell Reports, Vol 23, Iss 6, Pp 1754-1766 (2018)
Cell reports
Cell reports
SUMMARY T cells are strongly regulated by oxidizing environments and amino acid restriction. How T cells reprogram metabolism to adapt to these extracellular stress situations is not well understood. Here, we show that oxidizing environments and amin